Italy's electronic health record system for opioid agonist treatment
Zapisane w:
Serpelloni, G., ET AL., Italy's electronic health record system for opioid agonist treatment. Journal of Substance Abuse Treatment, Vol. 45, no. 2 (2013), p. 190-195.
Ref.
193286
Lokalizacja:
SIIS R.991 Archivo
Palabras clave:
Buprenorfina, Drogas ilegales, Drogodependencias, Historia clínica, Metadona, Nuevas tecnologías, Opiáceos, Programas de mantenimiento, Reducción de daños, Tratamiento médico, Italia
Buprenorfina, Drogas ilegales, Drogodependencias, Historia clínica, Metadona, Nuevas tecnologías, Opiáceos, Programas de mantenimiento, Reducción de daños, Tratamiento médico, Italia
Podobne zapisy: Italy's electronic health record system for opioid agonist treatment
- OPIOID AGONIST PHARMACOTHERAPY IN NEW SOUTHWALES FROM 1985 TO 2006: PATIENT CHARACTERISTICS AND PATTERNS AND PREDICTORS OF TREATMENT RETENTION
- The impact of cocaine use in patients enrolled in opioid agonist therapy in Ontario, Canada
- SUBOXONE (BUPRENORPHINE/NALOXONE) AS AN AGONIST OPIOID TREATMENT IN SPAIN: A BUDGETARY IMPACT ANALYSIS
- CLINICAL CHARACTERISTICS OF CENTRAL EUROPEAN AND NORTH AMERICAN SAMPLES OF PREGNANT WOMEN SCREENED FOR OPIOID AGONIST TREATMENT
- FROM MORPHINE CLINICS TO BUPRENORPHINE: REGULATING OPIOID AGONIST TREATMENT OF ADDICTION IN THE UNITED STATES
- High‐intensity cannabis use is associated with retention in opioid agonist treatment: a longitudinal analysis